Astrana Health, Inc.
ASTHHealthcareNASDAQMedical Care Facilities
Scan Results
Daily timeframeAstrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company carries a $1.91B market cap, placing it firmly in the small-cap category. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement.
Market Cap
$1.91B
Beta
0.91
P/E (TTM)
46.91
P/E (Fwd)
10.87
EPS (TTM)
$0.82
EPS (Fwd)
$3.54
ROE
6.9%
ROA
3.8%
Cash
$400.8M
Total Debt
$979.4M
Free CF
$231.2M
52W Change
30.4%
Annual Financials
Cash vs Debt
Where ASTH stands vs its 150-day and 200-day moving averages
As of the August 19, 2026 close, ASTH finished 20.16% above its 150-day moving average ($32.59) and 27.81% above its 200-day moving average ($30.64). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is ASTH overbought or oversold?
At the August 19, 2026 close, ASTH's RSI(14) was 57.3, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, ASTH has $400.8M in cash with $979.4M in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Annual free cash flow of $231.2M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of 6.9% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 3.8% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $1.14B (2022) to $3.18B (2025), reflecting a 178% increase over the period.
Investors considering Astrana Health, Inc. should weigh the typical risks associated with ASTH's sector, size, and financial profile against their own risk tolerance and investment objectives. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing ASTH.